Q2 2025 Ingevity Corp Earnings Call Transcript
Key Points
- Ingevity Corp (NGVT) reported a significant improvement in leverage, reducing it to three times, reflecting a full turn improvement in less than a year.
- The company achieved strong profitability driven by performance materials, with EBITDA margins above 50%, and a consolidated EBITDA margin of 30%.
- Ingevity Corp (NGVT) is making meaningful progress on its strategic portfolio assessment, with the sale process for its Industrial specialties business and CTO refinery reaching an advanced stage.
- The company raised the midpoint of its free cash flow guidance, expecting to achieve a year-end net leverage target of below 2.8 times.
- Ingevity Corp (NGVT) has posted three straight quarters of year-over-year improvement in EBITDA and free cash flow, demonstrating strong execution and momentum.
- Second quarter sales were down 7% compared to the previous year, primarily due to repositioning actions and external factors like wet weather and tariff impacts.
- The company recorded a non-cash goodwill impairment charge of $184 million for its APT segment due to shifts in customer order patterns and ongoing weakness in global industrial markets.
- Performance materials sales declined by about 2%, with declines in Europe and Asia offsetting higher revenue in North America.
- The APT segment experienced a 10% drop in sales due to weaker customer demand and price concessions, resulting in an EBITDA of about $1 million for the quarter.
- Performance chemicals sales were down about 10%, impacted by lower sales in Roadtec due to wet weather and the final remnants of revenue from exited lower margin markets.
Good morning or good afternoon, and welcome to the Ingevity Q2 2025 earnings call and webcast. My name is Adam and I will be your operator today. (Operator Instructions)
I will now hand the floor to John Nypaver to begin. So John, please go ahead when you are ready.
Thank you, Adam. Good morning, and welcome to Ingevity's second quarter 2025 Earnings Call. Earlier this morning, we posted a presentation on our investor site that you can use to follow today's discussion. It can be found on ir.ingevity.com under events and presentations. Also throughout this call, we may refer to non-GAAP financial measures, which are intended to supplement, not substitute for comparable GAAP measures.
Definitions of these non-GAAP financial measures and reconciliations to comparable GAAP measures are included in our earnings release and are also in our most recent Form 10-K. We may also make forward-looking statements regarding future events and future financial performance of the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

